A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects
In the register
The register attaches this trial to TDM-105795 (TechnoDerma Medicines), currently at “Phase 2” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Completed
- Declared phase
- Phase 1
- Sponsor
- Cutia Therapeutics（Wuxi）Co.,Ltd
- Participants (registry)
- 80
- Start
- August 2022
- Primary completion
- November 2023
- Study completion
- February 2024
- Last registry update
- September 2024
- Countries
- China
Conditions studied: AGA
Interventions: CU-40101
Other trials of TDM-105795
Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.